The process for obtaining NMPA certification (National Medical Products Administration) for invasive blood pressure monitoring devices in China typically involves several key steps:
Classification of the Device:
- Determine the classification of your invasive blood pressure monitoring device according to Chinese regulations. Classification is based on factors such as intended use, technology, and potential risks.
Preparation of Application Documents:
- Gather and prepare necessary technical documentation, including:
- Device specifications and labeling
- Design drawings and manufacturing process details
- Clinical evaluation data and test reports demonstrating compliance with relevant Chinese standards (e.g., GB standards)
- Quality management system documentation (e.g., ISO 13485 certification)
Appointment of a Local Agent:
- Engage a Chinese legal entity (such as a regulatory consultant or local representative) to act as your agent in China. This agent will submit your application and liaise with the NMPA on your behalf.
Application Submission:
- Submit your application to the NMPA through your appointed local agent. Ensure all required forms are completed accurately and all necessary documentation is included.
Technical Review:
- The NMPA will conduct a technical review of your application, assessing the submitted documentation, test reports, and clinical data to ensure compliance with Chinese regulatory requirements.
Site Inspection (if applicable):
- Depending on the risk classification of your device, the NMPA may require an on-site inspection of your manufacturing facilities. This inspection aims to verify compliance with Good Manufacturing Practices (GMP) and other quality system requirements.
Review and Approval:
- If your application and supporting documents meet all regulatory requirements and pass the technical review (and inspection, if applicable), the NMPA will issue a Registration Certificate for your invasive blood pressure monitoring device.
Post-Market Surveillance:
- After obtaining certification, comply with post-market surveillance requirements, which may include monitoring and reporting adverse events, maintaining product quality, and updating the NMPA on any significant changes to the device or manufacturing processes.

Contact Us:
Whatsapp or Wechat:+86 15816864648;email address:hito.lin@grzan.cn